Global /Taiwan /Healthcare /Biotechnology /6939

TFBS Bioscience Inc.

6939

• TPEX: 6939 • Delayed

23.45TWD -4.1%

0.7412 USD

As of 20 June 2026, TFBS Bioscience Inc. has a market cap of $27.02M USD, ranking #34965 globally and #2145 in Taiwan. It ranks #3158 in the Healthcare sector, and #607 in the Biotechnology industry.

Global Rank

34965

Country Rank

2145

Sector Rank

3158

Industry Rank

607

Key Stats

Market Cap

$27.02MUSD

854.26M TWD

Company Profile

Country (HQ)

Taiwan

Sector

Healthcare

Industry

Biotechnology

CEO

Tatung Yuan open_in_new

Employees

Founded

2016

Website

tfbsbio.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-4.1%	21%	27%	19%	0.6%	14%	-2.4%	-69%	-67%

News

Markets

Exchange	Ticker	Price	Quotes
Taipei Exchange (TPEX) MIC: ROCO PRIMARY	6939 啓弘生物科技股份有限公司 ISIN: TW0006939002 Shares Out.: Shares Outstanding: 35.399M¹ TV: TradingView: TPEX: 6939 SA: Stock Analysis: TPEX: 6939 YF: Yahoo Finance: 6939.TWO GF: Google Finance: TPEX: 6939 BA: Barron's: 6939 MS: Morningstar: ROCO: 6939	23.45 TWD	TV: TradingView: TPEX: 6939 SA: Stock Analysis: TPEX: 6939 YF: Yahoo Finance: 6939.TWO GF: Google Finance: TPEX: 6939 BA: Barron's: 6939 MS: Morningstar: ROCO: 6939

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About TFBS Bioscience Inc.

TFBS Bioscience Inc., a contract research organization, provides biological testing services in Taiwan. It offers viral vector manufacturing services for cell and gene therapy products; and biosafety testing and product release testing for cell and gene therapy products, vaccines, and biologic products. The company was incorporated in 2016 and is headquartered in New Taipei City, Taiwan.

Similar Companies

Industry: Biotechnology (Taiwan)

Name	Market Cap (USD) diff.	PE	Country
Caliway Biopharmaceuticals Co., Ltd. TWSE: 6919	$5.46B 172.76B TWD 20K%	-	Taiwan
Pell Bio-Med Technology Co., Ltd. TWSE: 6949	$1.61B 50.93B TWD 6K%	-	Taiwan
Lin BioScience, Inc. TPEX: 6696	$1.08B 34.04B TWD 4K%	-	Taiwan
HanchorBio Inc. TWSE: 7827	$726.25M 22.97B TWD 3K%	-	Taiwan
HanchorBio Inc. TPEX: 7827	$600.25M 18.98B TWD 2K%	-	Taiwan
Locus Cell Co., Ltd. TPEX: 06891	$571.26M 18.06B TWD 2K%	-	Taiwan

Industry: Biotechnology (Global)

Name	Market Cap (USD) diff.	PE	Country
Amgen Inc. NASDAQ: AMGN	$182.42B 675K%	23.9	United States
Gilead Sciences, Inc. NASDAQ: GILD	$159.92B 592K%	19.0	United States
argenx SE EBR: ARGX	$47.43B 41.39B EUR 175K%	39.9	Netherlands
Samsung Biologics Co.,Ltd. KRX: 207940	$44.23B 68.19T KRW 164K%	35.5	South Korea
CSL Ltd. ASX: CSL	$42.27B 60.27B AUD 156K%	29.3	Australia
Lonza Group AG SIX: LONN	$41.88B 33.71B CHF 155K%	37.2	Switzerland

chevron_leftBack